TERMINATION AGREEMENT AND RELEASETermination Agreement • October 28th, 2014 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations
THIS TERMINATION AGREEMENT AND RELEASE (hereinafter referred to as this “Agreement”) is made and entered into as of September 19, 2014 (the “Effective Date”), by and among Shin Nippon Biomedical Laboratories, Ltd., a Japanese corporation (“SNBL”) and Transcept Pharmaceuticals, Inc., a Delaware corporation (“Transcept”). SNBL and Transcept may each be referred to herein as a “Party” or collectively as the “Parties.”
